A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone

Autor: Faiez Zannad, Victoria Cachofeiro, M.A. Fortuño, Javier Díez, Beatriz Martín-Fernández, Patrick Rossignol, Vicente Lahera, Natalia López-Andrés
Rok vydání: 2011
Předmět:
Male
Physiology
Blood Pressure
Spironolactone
Left ventricular hypertrophy
Ventricular Function
Left

Muscle hypertrophy
chemistry.chemical_compound
Mice
Fibrosis
Heart Rate
Aldosterone
Mineralocorticoid Receptor Antagonists
Mice
Knockout

Ventricular Remodeling
Hypertension
Ventricular pressure
Cytokines
Hypertrophy
Left Ventricular

Collagen
Inflammation Mediators
Cardiology and Cardiovascular Medicine
endocrine system
medicine.medical_specialty
Cardiotrophin 1
medicine.drug_class
Blotting
Western

Enzyme-Linked Immunosorbent Assay
Real-Time Polymerase Chain Reaction
Physiology (medical)
Internal medicine
Hyperaldosteronism
medicine
Ventricular Pressure
Animals
Rats
Wistar

Sodium Chloride
Dietary

Ventricular remodeling
Inflammation
business.industry
Myocardium
medicine.disease
Rats
Mice
Inbred C57BL

Disease Models
Animal

Endocrinology
chemistry
Mineralocorticoid
business
Zdroj: American journal of physiology. Heart and circulatory physiology. 301(6)
ISSN: 1522-1539
Popis: Hyperaldosteronim is associated with left ventricular (LV) hypertrophy (LVH) and fibrosis. Cardiotrophin (CT)-1 is a cytokine that induces myocardial remodeling. We investigated whether CT-1 mediates aldosterone (Aldo)-induced myocardial remodeling in two experimental models. Wistar rats were treated with Aldo-salt (1 mg·kg−1·day−1) with or without spironolactone (200 mg·kg−1·day−1) for 3 wk. Wild-type (WT) and CT-1-null mice were infused with Aldo (1 mg·kg−1·day−1) for 3 wk. Hemodynamic parameters were analyzed. LVH, fibrosis, inflammation, and CT-1 expression were evaluated in both experimental models by histopathological analysis, RT-PCR, Western blot analysis, and ELISA. Hypertensive Aldo-treated rats exhibited increased LV end-diastolic pressure and −dP/d t compared with controls. The cardiac index, LV cross-sectional area and wall thickness, cardiomyocyte size, collagen deposition, and inflammation were increased in Aldo-salt-treated rats. Myocardial expression of molecular markers assessing LVH and fibrosis as well as CT-l levels were also augmented by Aldo-salt. Spironolactone treatment reversed all the above effects. CT-1 correlated positively with hemodynamic, histological, and molecular parameters showing myocardial remodeling. In WT and CT-1-null mice, Aldo infusion did not modify blood pressure. Whereas Aldo treatment induced LVH, fibrosis, and inflammation in WT mice, the mineralocorticoid did not provoke cardiac remodeling in CT-1-null mice. In conclusion, in experimental hyperaldosteronism, the increase in CT-1 expression was associated with parameters showing LVH and fibrosis. CT-1-null mice were resistant to Aldo-induced LVH and fibrosis. These data suggest a key role for CT-1 in cardiac remodeling induced by Aldo independent of changes in blood pressure levels.
Databáze: OpenAIRE